Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Batch consistency trial of diphtheria, tetanus and acellular pertussis (three-component) combined vaccine (adsorbed)
CTR20250685Phase 3Active
- Sponsor
- CanSino Biologics Inc.
- Start
- Mar 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of diphtheria + tetanus + acellular pertussis vaccine, adsorbed in pertussis, diphtheria, Tetanus, sponsored by CanSino Biologics Inc.. Started Mar 2025; status: active.
02
Drugs
diphtheria + tetanus + acellular pertussis vaccine, adsorbed
03
Conditions
pertussisdiphtheriaTetanus
Beyond the preview
Go deeper on CTR20250685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250685.